Eric Christopher Anderson, DPM | |
1134 N Main St, Suite 3100, Bellefontaine, OH 43311-2379 | |
(937) 599-1280 | |
(937) 651-6442 |
Full Name | Eric Christopher Anderson |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 17 Years |
Location | 1134 N Main St, Bellefontaine, Ohio |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1356507149 | NPI | - | NPPES |
H015111 | Other | OH | MEDICARE |
3031329 | Medicaid | OH | |
H015112 | Other | OH | MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | 36003530 (Ohio) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Ohiohealth Home Health | Worthington, OH | Home health agency |
Riverside Methodist Hospital | Columbus, OH | Hospital |
Mary Rutan Hospital | Bellefontaine, OH | Hospital |
Provider Name | Mary Rutan Hospital |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1548254931 PECOS PAC ID: 9032013792 Enrollment ID: O20031124000531 |
News Archive
Media outlets report on what Rick Santorum did after he left the Senate and what he would have on his to-do list if elected, the continuing "risks" Mitt Romney faces from the left and the right, and on an ethics group that is directing a challenge at Newt Gingrich.
Increased adoption of new digital technology has underpinned businesses' response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced that updated clinical data evaluating CAL-101, an oral, PI3K inhibitor, in patients with hematologic malignancies, will be presented during a poster discussion session at the 2010 American Society of Clinical Oncology Annual Meeting taking place June 4-8, 2010 at McCormick Place in Chicago, IL.
A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent.
› Verified 1 days ago
Provider Name | Complete Foot And Ankle Specialists Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1184970121 PECOS PAC ID: 1951551027 Enrollment ID: O20121025000698 |
News Archive
Media outlets report on what Rick Santorum did after he left the Senate and what he would have on his to-do list if elected, the continuing "risks" Mitt Romney faces from the left and the right, and on an ethics group that is directing a challenge at Newt Gingrich.
Increased adoption of new digital technology has underpinned businesses' response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced that updated clinical data evaluating CAL-101, an oral, PI3K inhibitor, in patients with hematologic malignancies, will be presented during a poster discussion session at the 2010 American Society of Clinical Oncology Annual Meeting taking place June 4-8, 2010 at McCormick Place in Chicago, IL.
A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent.
› Verified 1 days ago
Provider Name | Central Ohio Wound Care Specialists |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1144936477 PECOS PAC ID: 8527432434 Enrollment ID: O20230316000145 |
News Archive
Media outlets report on what Rick Santorum did after he left the Senate and what he would have on his to-do list if elected, the continuing "risks" Mitt Romney faces from the left and the right, and on an ethics group that is directing a challenge at Newt Gingrich.
Increased adoption of new digital technology has underpinned businesses' response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced that updated clinical data evaluating CAL-101, an oral, PI3K inhibitor, in patients with hematologic malignancies, will be presented during a poster discussion session at the 2010 American Society of Clinical Oncology Annual Meeting taking place June 4-8, 2010 at McCormick Place in Chicago, IL.
A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Eric Christopher Anderson, DPM 205 E Palmer Rd, Bellefontaine, OH 43311-2281 Ph: (937) 592-4015 | Eric Christopher Anderson, DPM 1134 N Main St, Suite 3100, Bellefontaine, OH 43311-2379 Ph: (937) 599-1280 |
News Archive
Media outlets report on what Rick Santorum did after he left the Senate and what he would have on his to-do list if elected, the continuing "risks" Mitt Romney faces from the left and the right, and on an ethics group that is directing a challenge at Newt Gingrich.
Increased adoption of new digital technology has underpinned businesses' response to COVID-19, with four in ten citing it as both vital to retaining jobs, and the ongoing viability of their business model, according to a new report from the University of Liverpool.
Calistoga Pharmaceuticals, Inc., the leader in the development of isoform-selective phosphatidylinositol 3 kinase inhibitors for the treatment of cancer and inflammatory diseases, today announced that updated clinical data evaluating CAL-101, an oral, PI3K inhibitor, in patients with hematologic malignancies, will be presented during a poster discussion session at the 2010 American Society of Clinical Oncology Annual Meeting taking place June 4-8, 2010 at McCormick Place in Chicago, IL.
A combination of brain scanning with a new imaging agent and cerebrospinal fluid (CSF) analysis has left neuroscientists encouraged that they may finally be moving toward techniques for diagnosing Alzheimer's disease before its clinical symptoms become apparent.
› Verified 1 days ago
Richard Shramo, D.P.M Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 834 N Main St, Bellefontaine, OH 43311 Phone: 937-592-9545 Fax: 937-592-9790 | |
Richard F Jennings, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1400 S Main St, Bellefontaine, OH 43311 Phone: 937-599-3668 Fax: 937-599-4852 | |
Grand Lake Podiatry Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 3772 Us Rt 68 S, Bellefontaine, OH 43311 Phone: 937-599-3668 Fax: 937-599-4852 | |
Complete Foot And Ankle Specialists, Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 1400 S Main St, Bellefontaine, OH 43311 Phone: 937-599-3668 Fax: 937-599-4852 | |
Gentle Footcare Llc Podiatrist Medicare: Medicare Enrolled Practice Location: 3722 Us Highway 68 S, Bellefontaine, OH 43311 Phone: 937-599-2600 Fax: 937-599-2602 | |
Dr. Jennifer L. Regler, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3722 Us Highway 68 South, Bellefontaine, OH 43311 Phone: 937-599-2600 Fax: 937-599-2602 |